These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 483253)

  • 1. No crossreaction between circulating plasminogen activator and urokinase.
    Astedt B
    Thromb Res; 1979; 14(4-5):535-9. PubMed ID: 483253
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture.
    Astedt B; Holmberg L
    Nature; 1976 Jun; 261(5561):595-7. PubMed ID: 819839
    [No Abstract]   [Full Text] [Related]  

  • 3. Occurrence of both urokinase and tissue plasminogen activator in human seminal plasma.
    Astedt B; Wallén P; Aasted B
    Thromb Res; 1979; 16(3-4):463-72. PubMed ID: 516004
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of IUD on urokinase-like immunoreactivity and plasminogen activators in human uterine fluid.
    Casslén B; Thorell J; Astedt B
    Contraception; 1981 Apr; 23(4):435-45. PubMed ID: 7023822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies on urokinase and plasminogen activator from cultured pancreatic carcinoma.
    Wu MC; Yunis AA
    Int J Biochem; 1979; 10(12):1001-6. PubMed ID: 116877
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunological characterization of plasminogen activators in human mixed saliva.
    Kjaeldgaard A; Kjaeldgaard M
    Acta Physiol Scand; 1986 Mar; 126(3):443-7. PubMed ID: 3515850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue plasminogen activator activity in prostatic cancer.
    Köller A; Kirchheimer J; Pflüger H; Binder BR
    Eur Urol; 1984; 10(6):389-94. PubMed ID: 6085049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between tissue plasminogen activator and the activators in blood and vascular wall.
    Rijken DC; Wijngaards G; Welbergen J
    Thromb Res; 1980 Jun; 18(6):815-30. PubMed ID: 7191151
    [No Abstract]   [Full Text] [Related]  

  • 9. A bispecific antibody enhances the fibrinolytic potency of single-chain urokinase.
    Charpie JR; Runge MS; Matsueda GR; Haber E
    Biochemistry; 1990 Jul; 29(27):6374-8. PubMed ID: 1698452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological comparison between human and rat plasminogen activators in blood and the vessel wall.
    Kjaeldgaard A; Larsson B; Astedt B
    J Clin Pathol; 1984 Oct; 37(10):1153-6. PubMed ID: 6541663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human synovial fibroblasts produce urokinase-type plasminogen activator.
    Medcalf RL; Hamilton JA
    Arthritis Rheum; 1986 Nov; 29(11):1397-401. PubMed ID: 3096341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase-type plasminogen activator antigen and early relapse in breast cancer.
    Jänicke F; Schmitt M; Ulm K; Gössner W; Graeff H
    Lancet; 1989 Oct; 2(8670):1049. PubMed ID: 2572788
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological characterisation of plasminogen activators in the human vessel wall.
    Ljungnér H; Holmberg L; Kjeldgaard A; Nilsson IM; Astedt B
    J Clin Pathol; 1983 Sep; 36(9):1046-9. PubMed ID: 6684128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of fibrinolytic capacity in plasma during thrombolytic therapy with single (scu-PA) or two-chain urokinase type plasminogen activator (tcu-PA) by a combined assay system for urokinase type plasminogen activator antigen and function.
    Wojta J; Binder BR; Huber K; Hoover RL
    Thromb Haemost; 1989 Apr; 61(2):289-93. PubMed ID: 2501899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological identification and comparison of plasminogen activator forms in cultured normal human endothelial cells and smooth muscle cells.
    Booyse FM; Scheinbuks J; Radek J; Osikowicz G; Feder S; Quarfoot AJ
    Thromb Res; 1981 Dec 1-15; 24(5-6):495-504. PubMed ID: 7201174
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunochemical characterization of human plasminogen activators.
    Aasted B
    Biochim Biophys Acta; 1981 May; 668(3):339-48. PubMed ID: 7195285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and purification of plasminogen activator from Yoshida ascites Sarcoma of rats.
    Nulkar MW; Pawse AR
    Indian J Biochem Biophys; 1991 Feb; 28(1):46-51. PubMed ID: 1905268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological characterization of plasminogen activator activities in human tissues and body fluids.
    Rijken DC; Wijngaards G; Welbergen J
    J Lab Clin Med; 1981 Apr; 97(4):477-86. PubMed ID: 6782183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies against urokinase.
    Hérion P; Glineur C; Franssen JD; Urbain J; Bollen A
    Biosci Rep; 1981 Nov; 1(11):885-92. PubMed ID: 7030431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.